Android app Apple app link

Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Analyst Forecast

NYSE Currency in USD Disclaimer
Add to Alerts ADD TO LIST

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$9.26
Day's range
$12.1

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date		 Details
05/13/2026 Morgan Stanley Terence Flynn $18.00 $8.93   101.57%
03/04/2026 H.C. Wainwright Douglas Tsao $10.00 $10.39   -3.75%
03/03/2026 Leerink Partners Marc Goodman $15.00 $10.67   40.58%
11/05/2025 Robert W. Baird Brian Skorney $42.00 $13.95   201.08%
12/04/2024 RBC Capital Leonid Timashev $61.00 $46.58   30.97%
10/15/2024 Bank of America Securities Jason Gerberry $65.00 $52.77   23.18%
09/24/2024 Leerink Partners Marc Goodman $60.00 $44.22   35.69%
09/24/2024 H.C. Wainwright Douglas Tsao $59.00 $45.94   28.43%
09/24/2024 Bank of America Securities Jason Gerberry $62.00 $45.94   34.96%
09/24/2024 RBC Capital Leonid Timashev $68.00 $45.94   48.02%
09/23/2024 Robert W. Baird Brian Skorney $60.00 $46.56   28.87%
09/23/2024 BTIG Thomas Shrader $59.00 $46.56   26.72%
09/16/2024 Jefferies Amy Li $57.00 $38.08   49.68%
09/04/2024 Tudor Pickering William Pickering $55.00 $38.17   44.09%
07/24/2024 Morgan Stanley Terence Flynn $58.00 $37.81   53.4%
05/29/2024 Robert W. Baird Brian Skorney $58.00 $30.31   91.36%
05/29/2024 RBC Capital Leonid Timashev $59.00 $28.69   105.65%

Biohaven Ltd FAQ's

Biohaven Ltd has been rated by research analysts at Morgan Stanley, H.C. Wainwright, Leerink Partners, Goldman Sachs, RBC Capital, UBS in the past 90 days.

Exclusive Content

Access to this content is reserved for premium members. Unlock all features by upgrading to a premium membership.

Get the App

To join as a premium member, please download our app and complete your membership purchase there.